======= AGBL1 =======
== Gene Information ==
* **Official Symbol**: AGBL1
* **Official Name**: ATP/GTP binding protein like 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=123624|123624]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96MI9|Q96MI9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=AGBL1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AGBL1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/615496|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: Polyglutamylation is a reversible posttranslational modification catalyzed by polyglutamylases that results in the addition of glutamate side chains on the modified protein. This gene encodes a glutamate decarboxylase that catalyzes the deglutamylation of polyglutamylated proteins. Mutations in this gene result in dominant late-onset Fuchs corneal dystrophy. [provided by RefSeq, Nov 2013].
* **UniProt Summary**: Metallocarboxypeptidase that mediates deglutamylation of target proteins. Catalyzes the deglutamylation of polyglutamate side chains generated by post-translational polyglutamylation in proteins such as tubulins. Also removes gene-encoded polyglutamates from the carboxy-terminus of target proteins such as MYLK. Acts as a long-chain deglutamylase and specifically shortens long polyglutamate chains, while it is not able to remove the branching point glutamate, a process catalyzed by AGBL5/CCP5. {ECO:0000250|UniProtKB:Q09M05}.
|Peptidase M14|
|protein side chain deglutamylation|
|C-terminal protein deglutamylation|
|protein deglutamylation|
|C-terminal protein amino acid modification|
|metallocarboxypeptidase activity|
|peptidyl-glutamic acid modification|
|tubulin binding|
|post-translational protein modification|
|zinc ion binding|
|peptidyl-amino acid modification|
|proteolysis|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp502|Milciclib 2μM R08 exp502]]|-2.19|
|[[:results:exp122|Golgicide-A 4μM R03 exp122]]|1.7|
|[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|1.74|
|[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.87|
|[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|2.05|
|[[:results:exp131|L-74142 5μM R03 exp131]]|2.06|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4031
* **Expression level (log2 read counts)**: -7.68
{{:chemogenomics:nalm6 dist.png?nolink |}}